Form 4: Immix Biopharma Director Carey Ng Reports Transaction in Company Stock
SEC Form 4
Director Carey Ng reports purchasing 10,000 shares of Immix Biopharma at an average price of $1.86 and disposing of 20,000 shares.
Summary
- On August 16, 2024, Carey Ng, a director of Immix Biopharma, Inc., purchased 10,000 shares of common stock at a weighted average price of $1.86.
- The transactions were executed in multiple trades with prices ranging from $1.84 to $1.915.
- Ng also disposed of 20,000 shares.
- Following the reported transaction, Ng beneficially owns 1,025,221 shares indirectly through Mesa Verde Venture Partners III, LP.
Sentiment
Score: 5
Explanation: This is a neutral report of insider trading activity, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, engages in transactions involving the company's stock.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 12/15/2021 | Date of Power of Attorney filing referenced in the remarks section. |
| 08/16/2024 | Date of the stock transaction (purchase and disposal) reported in the Form 4. |
| 08/19/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.